166 related articles for article (PubMed ID: 16670929)
1. Normocalcemic primary hyperparathyroidism in patients with recurrent kidney stones: pathological analysis of parathyroid glands.
Yang AH; Hsu CW; Chen JY; Tseng LM; Won GS; Lee CH
Virchows Arch; 2006 Jul; 449(1):62-8. PubMed ID: 16670929
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening.
Lundgren E; Ridefelt P; Akerström G; Ljunghall S; Rastad J
World J Surg; 1996 Sep; 20(7):727-34; discussion 735. PubMed ID: 8678973
[TBL] [Abstract][Full Text] [Related]
3. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
[TBL] [Abstract][Full Text] [Related]
4. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
5. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
6. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
8. Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.
Fan Y; Liu W; Bi R; Densmore MJ; Sato T; Mannstadt M; Yuan Q; Zhou X; Olauson H; Larsson TE; Toka HR; Pollak MR; Brown EM; Lanske B
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3749-E3758. PubMed ID: 29618612
[TBL] [Abstract][Full Text] [Related]
9. The effect of parathyroidectomy in patients with normocalcemic calcium stones.
Siminovitch JM; James RE; Esselstyn CB; Straffon RA; Banowsky LH
J Urol; 1980 Mar; 123(3):335-7. PubMed ID: 7359630
[TBL] [Abstract][Full Text] [Related]
10. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism.
Pepe J; Magna A; Sonato C; Sgreccia A; Colangelo L; Occhiuto M; Cilli M; Minisola S; Cipriani C
J Endocrinol Invest; 2024 Jun; 47(6):1499-1504. PubMed ID: 38141155
[TBL] [Abstract][Full Text] [Related]
12. Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery.
Siperstein AE; Shen W; Chan AK; Duh QY; Clark OH
Arch Surg; 1992 Oct; 127(10):1157-6; discussion 1161-3. PubMed ID: 1417479
[TBL] [Abstract][Full Text] [Related]
13. [Should the parathyroid function be evaluated in a patient with calcium kidney stones? If so, when and why?].
Gardin JP; Houillier P; Borensztein P; Paillard M
Nephrologie; 1991; 12(2):71-7. PubMed ID: 1944759
[TBL] [Abstract][Full Text] [Related]
14. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
Levine MA; Dempsey MA; Helman LJ; Ahn TG
J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
[TBL] [Abstract][Full Text] [Related]
15. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
16. PRIMARY HYPERPARATHYROIDISM, WITH A FOCUS ON MANAGEMENT OF THE NORMOCALCEMIC FORM: TO TREAT OR NOT TO TREAT?
Šiprová H; Fryšák Z; Souček M
Endocr Pract; 2016 Mar; 22(3):294-301. PubMed ID: 26523628
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of parathyroid surgery in normocalcaemic patients with recurrent renal stones.
Ljunghall S; Källsen R; Backman U; Danielson BG; Grimelius L; Johansson H; Thorén L; Werner I
Acta Chir Scand; 1980; 146(3):161-9. PubMed ID: 7468037
[TBL] [Abstract][Full Text] [Related]
18. The role of ionized calcium in the diagnosis of subtle hypercalcemia in symptomatic primary hyperparathyroidism.
McLeod MK; Monchik JM; Martin HF
Surgery; 1984 Jun; 95(6):667-73. PubMed ID: 6729704
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.
Irvin GL; Newell DJ; Morgan SD
Surgery; 1987 Dec; 102(6):898-902. PubMed ID: 3686352
[TBL] [Abstract][Full Text] [Related]
20. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
